Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J128- Other viral pneumonia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: I. All patients with age more than 18 years who are asymptomatic,mild cases of COVID-19 who are under home isolation II. COVID-19 positive cases under home isolation who consents for the study III. Household contacts of home isolated COVID-19 patients who are able to understand and follow/perform the interventions.
Exclusion criteria
Exclusion criteria: i. Patients with known history of immuno-suppressive disorders ii. Patients with known history of hyperthyroidism and other thyroid diseases and with symptoms suggestive of thyroid dysfunction like tremors, palpitation, heat/cold intolerance, lethargy, menstrual irregularities etc iii. Pregnant and lactating women iv. Patients with nasal polyps, recurrent nasal bleeding v. Patients with known allergy to iodine and its compounds and on Lithium therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Reduction in severity of symptoms (VAS, temperature etc) in mild cases 2) Early negativity of the RT PCR in nasopharyngeal swab among the intervention group when compared to the controls 3) Reduction in transmission of infection among household members of COVID-19 patient Timepoint: 1) Baseline assessment and daily follow up of symptoms till 21 days 2) Baseline swab test and swab test once every 3 days till two successive tests are negative 3) Baseline symptomatic assessment of contacts and daily follow up of evolution of symptoms till 21 days and one swab test between 5th to 10th days of contact to assess transmission pattern. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in transmission of infection among household members of COVID-19 patient Timepoint: 21 days | — |
Countries
India
Contacts
Bangalore medical college and Research institute